Company: SMNR
Filing Date: 2025-07-23
Form Type: S-4/A
Source: 0001193125-25-163401
Chunk: 626

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-07-23
Form: S-4/A
Chunk 626
---
 if it deems appropriate, recommending to the New Semnur Board for determination and approval) the compensation and terms of employment of New Semnur’s Chief Executive Officer, including seeking to achieve an appropriate level of risk and reward in determining the long-term incentive component of the compensation of the Chief Executive Officer; |

383

| • |     | determining and approving (or, if it deems appropriate, recommending to the New Semnur Board for determination and approval) the compensation and terms of employment of New Semnur’s executive officers and other members of senior management; |

| • |     | reviewing and approving (or, if it deems appropriate, making recommendations to the New Semnur Board regarding) the terms of employment agreements and severance agreements, |

| • |     | change-of-control protections and other compensatory arrangements for New Semnur’s executive officers and other members of senior management; |

| • |     | conducting periodic reviews of the base compensation levels of all of New Semnur’s employees generally; |

| • |     | reviewing and approving compensation programs as well as the type and amount of compensation to be paid or awarded to non-employee directors; |

| • |     | reviewing and approving the adoption, amendment and termination of New Semnur’s stock option plans, stock appreciation rights plans, pension and profit sharing plans, incentive plans, stock bonus plans, stock purchase plans, bonus plans, deferred compensation plans, 401(k) plans, supplemental retirement plans and similar programs, if any, and the aggregate cash amounts and numbers of shares to be paid or reserved for issuance thereunder; and administering all such plans, establishing guidelines, interpreting plan documents, selecting participants, approving grants and awards and exercising such other power and authority as may be permitted or required under such plans; |

| • |     | reviewing New Semnur’s incentive compensation arrangements to determine whether such arrangements encourage excessive risk-taking, reviewing and discussing at least annually the relationship between New Semnur’s risk management policies and practices and compensation and evaluating compensation policies and practices that could mitigate any such risk; and |

| • |     | reviewing human capital management strategies, programs and policies, including, but not limited to, those regarding recruitment, retention, career development, diversity, equity and inclusion, pay equity, workplace culture and employee engagement. |

In addition, once New Semnur ceases to be an “emerging growth company,” as defined in the JOBS Act, the responsibilities of the compensation committee will also include: